A bill passed yesterday by the DC Council would make the District only jurisdiction in the country to require licenses to sell pharmaceuticals within its boundaries. Supporters say it’s necessary to keep costs down and keep sales-representatives honest. The industry says it’s a dangerous precedent and unreasonable burden. Join Kojo for details on the SafeRX Act.

Guests

  • Marjorie Powell Senior Assistant General Counsel, Pharmaceutical Research and Manufacturers of America
  • David Catania D.C. Councilmember (I-At Large); Chairman of the Committee on Health

Topics + Tags

Most Recent Shows